文献速递创伤骨科关节外科骨质疏松与代谢性骨病

载美罗培南骨水泥在动物模型中有效预防革兰阴性菌骨感染

Meropenem-loaded Cement Is Effective in Preventing Gram-negative Osteomyelitis in an Animal Model.
PubMed 文献 · Clin Orthop Relat Res · 2022-09-21

该研究通过体外实验评估6种抗生素骨水泥的力学强度、释放和抗菌性能,并在大鼠胫骨关节置换模型中比较载美罗培南骨水泥与无抗生素骨水泥对铜绿假单胞菌感染的预防效果。结果显示载美罗培南骨水泥具有稳定抗菌活性和良好力学释放特性,大鼠模型中的体重、影像学、炎症指标及细菌学等多项指标均优于对照组。作者认为其可能成为预防革兰阴性菌骨感染的有效措施,但尚需更多临床研究评估安全性和有效性。

要点

  • 载美罗培南骨水泥在体外对大肠埃希菌、铜绿假单胞菌、肺炎克雷伯菌和普通变形杆菌均有抗菌活性。
  • 大鼠模型中,载美罗培南骨水泥组体重、膝关节宽度及影像学评分等指标均优于无抗生素骨水泥对照组。
  • 作者认为载美罗培南骨水泥可能有效预防革兰阴性菌骨感染,但需更多临床研究评估安全性和有效性。

核心结论

  • 作者认为载美罗培南骨水泥体外抗菌活性最稳定、体内有效且力学和释放特性可接受,可能成为预防革兰阴性菌骨感染的有效措施。

研究设计与样本

  • 体外研究评估6种抗生素骨水泥的力学强度、释放和抗菌性能,并结合大鼠模型评估载美罗培南骨水泥的体内效果。
  • 体外实验将2克头孢他啶、妥布霉素、美罗培南、哌拉西林、环丙沙星或氨曲南加入40克丙烯酸骨水泥中。
  • 所有大鼠右胫骨行关节置换并植入骨水泥,膝关节接种铜绿假单胞菌,术后14天评估各项指标。

主要发现

  • 所有抗生素骨水泥组合的抗压强度均超过ISO 5833规定的70 MPa阈值。
  • 28天内累积释放量:妥布霉素1182.8±37.9 µg、美罗培南355.6±16.2 µg、哌拉西林721.2±40.3 µg、头孢他啶477.4±37.1 µg、环丙沙星146.5±11.3 µg、氨曲南372.1±14.5 µg。
  • 体外28天内,载美罗培南骨水泥对四种测试革兰阴性菌(大肠埃希菌、铜绿假单胞菌、肺炎克雷伯菌、普通变形杆菌)均有抗菌活性;环丙沙星骨水泥抑制大肠埃希菌,头孢他啶和氨曲南骨水泥抑制肺炎克雷伯菌,妥布霉素骨水泥抑制铜绿假单胞菌;仅美罗培南在琼脂扩散实验中对所有革兰阴性菌显示抗菌活性。

临床怎么用

  • 作者认为载美罗培南丙烯酸骨水泥是预防革兰阴性菌所致骨感染的潜在有效措施,但尚需更多相关临床研究进一步评估其安全性和有效性。

局限性

  • 作者在临床相关性中指出,尚需更多相关临床研究进一步评估载美罗培南骨水泥的安全性和有效性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Low-dose antibiotic-loaded acrylic cement is routinely used for preventing skeletal infection or reimplantation in patients with periprosthetic joint infections. However, few reports about the selection of antibiotics in acrylic cement for antigram-negative bacteria have been proposed. QUESTIONS/PURPOSES: (1) Does the addition of antibiotics (tobramycin, meropenem, piperacillin, ceftazidime, ciprofloxacin, and aztreonam) to acrylic cement adversely affect compressive strength before and after elution? (2) Which antibiotics have the highest cumulative release within 28 days? (3) Which antibiotics showed antimicrobial activity within 28 days? (4) Does meropenem-loaded cement improve body weight, temperature, and other inflammatory markers compared with control unloaded cement? METHODS: This is an in vitro study that assessed the mechanical strength, antibiotic elution, and antibacterial properties of antibiotic-loaded cement, combined with an animal study in a rat model that evaluated key endpoints from the animal study. In the in vitro study, we added 2 g of tobramycin (TOB), meropenem (MEM), piperacillin (PIP), ceftazidime (CAZ), ciprofloxacin (CIP), and aztreonam (ATM) to 40 g of acrylic cement. The compressive strength, elution, and in vitro antibacterial properties of the antibiotic-loaded cement were detected. Thirty male rats were randomly divided into two groups: CON (antibiotic-unloaded cement) and MEM (meropenem-loaded cement, which had the most stable antibacterial properties of the six tested antibiotic-loaded cements in vitro within 28 days). The right tibia of all rats underwent arthroplasty and was implanted with the cement, followed by inoculation with Pseudomonas aeruginosa in the knee. General status, serum biomarkers, radiology, microbiological assay, and histopathological tests were assessed over 14 days postoperatively. RESULTS: The compressive strength of all tested antibiotic cement combinations exceeded the 70 MPa threshold (the requirement established in ISO 5833). The cumulative release proportions of the raw antibiotic in cement were 1182.8 ± 37.9 µg (TOB), 355.6 ± 16.2 µg (MEM), 721.2 ± 40.3 µg (PIP), 477.4 ± 37.1 µg (CAZ), 146.5 ± 11.3 µg (CIP), and 372.1 ± 14.5 µg (ATM) within 28 days. Over a 28-day period, meropenem cement demonstrated antimicrobial activities against the four tested gram-negative bacteria ( Escherichia coli , P. aeruginosa , Klebsiella pneumoniae , and Proteus vulgaris ). Ciprofloxacin cement inhibited E. coli growth, ceftazidime and aztreonam cement inhibited K. pneumonia growth, and tobramycin cement inhibited P. aeruginosa . Only meropenem demonstrated antimicrobial activity against all gram-negative bacteria on agar diffusion bioassay. Rats treated with meropenem cement showed improved body weight (control: 280.1 ± 4.2 g, MEM: 288.5 ± 6.6 g, mean difference 8.4 [95% CI 4.3 to 12.6]; p < 0.001), improved knee width (control: 13.5 ± 0.3 mm, MEM: 11.8± 0.4 mm, mean difference 1.7 [95% CI 1.4 to 2.0]; p < 0.001), decreased inflammatory marker (control: 316.7 ± 45.0 mm, MEM: 116.5 ± 21.8 mm, mean difference 200.2 [95% CI 162.3 to 238.2]; p < 0.001), decreased radiographic scores (control: 17.7 ± 2.0 mm, MEM: 10.7± 1.3 mm, mean difference 7.0 [95% CI 5.4 to 8.6]; p < 0.001), improved bone volume/total volume (control: 8.7 ± 3.0 mm, MEM: 28.5 ± 5 .5 mm, mean difference 19.8 [95% CI 13.3 to 26.2]; p < 0.001), decreased Rissing scale scores of the knee gross pathology (control: 3.3 ± 0.5, MEM: 1.1 ± 0.7, mean difference 2.2 [95% CI 1.7 to 2.7]; p < 0.001), decreased Petty scale scores of knee synovium (control: 2.9 ± 0.4 mm, MEM: 0.7 ± 0.7 mm, mean difference 2.1 [95% CI 1.7 to 2.5]; p < 0.001), and decreased bacterial counts of the bone and soft tissues and negative bacterial cultures of cement (p < 0.001, p < 0.001, p < 0.001, p < 0.001, respectively). CONCLUSION: In this current study, MEM cement had the most stable in vitro antimicrobial activities, effective in vivo activity while having acceptable mechanical and elution characteristics, and it may be an effective prophylaxis against skeletal infection caused by gram-negative bacteria. CLINICAL RELEVANCE: Meropenem-loaded acrylic cement is a potentially effective prevention measure for skeletal infection caused by gram-negative bacteria; however, more related clinical research is needed to further evaluate the safety and efficacy.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Wei J, Zhou S, Gu H, et al. Meropenem-loaded Cement Is Effective in Preventing Gram-negative Osteomyelitis in an Animal Model. Clin Orthop Relat Res. 2022. PMID: 36135966. doi:10.1097/CORR.0000000000002364

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。